zilovertamab vedotin
merck
['zilovertamab', 'mantle,(-dismantle)', 'lymphoma', 'mk-2140', 'dlbcl', ' vedo']
a novel treatment demonstrated tolerability and efficacy for #lymphoma patients, including #mcl, #dlbcl, and richter s transformation, in this #ash22 abstract: s dr. richard furman breaks down these findings 
The Weill Cornell Medicine Lymphoma Program seeks to enable people with lymphoma to have the best possible clinical outcome. https://t.co/VB4txzzqth